Advanced Drug Delivery Reviews logo Elsevier logo

Publisher: Elsevier

Related content
Volume 55, Number 10, 26 September 2003

< previous issue | all issues | next issue >

Editorial Board
pp. ii-ii(1)

PEGylation of growth hormone-releasing hormone (GRF) analogues
pp. 1279-1291(13)
Authors: Esposito P.; Barbero L.; Caccia P.; Caliceti P.; D'Antonio M.; Piquet G.; Veronese F.M.

Pegaspargase: a review of clinical studies
pp. 1293-1302(10)
Author: Graham M.L.

Pegvisomant in the treatment of acromegaly
pp. 1303-1314(12)
Authors: Parkinson C.; Scarlett J.A.; Trainer P.J.

Design of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) for chronic inflammatory diseases
pp. 1315-1336(22)
Authors: Edwards C.K.; Martin S.W.; Seely J.; Kinstler O.; Buckel S.; Bendele A.M.; Ellen Cosenza M.; Feige U.; Kohno T.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page